TGRX-678 Chinese Phase II in Chronic Myelogenous Leukemia (CML) Patients | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
TGRX-678 Chinese Phase II in Chronic Myelogenous Leukemia (CML) Patients	Chronic Disease, Disease Attributes, Hemic and Lymphatic Diseases, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Myeloproliferative Disorders, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, bone marrow disorder, hematologic disorder, leukemia, leukemia, myeloid, accelerated-phase, myeloid leukemia, neoplasm	Recruiting	Phase 2	2025-02-21		NCT06453902

11 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Chinese Academy of Medical Sciences	36
First Affiliated Hospital of Zhejiang University	201
Henan Cancer Hospital	147
Huazhong University of Science and Technology	83
Nanfang Hospital, Southern Medical University	248
Peking University People's Hospital	269
Ruijin Hospital	454
Shengjing Hospital	111
Shenzhen Second People's Hospital	31
Shenzhen TargetRx Co., Ltd.	9
The First Affiliated Hospital of Soochow University	164

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Peking University People's Hospital	Beijing	China	146